Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exablate blood-brain barrier disruption with carboplatin in recurrent glioblastoma
NCT04440358Phase 2Completed
- Sponsor
- Insightec
- Start
- Oct 2020
- Primary completion
- Nov 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of carboplatin in glioblastoma (GBM), sponsored by Insightec. Started Oct 2020; status: completed.
02
Drugs
carboplatin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04440358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04440358.